See original story here ABK Biomedical Inc., a company dedicated to the research, development and commercialization of innovative embolic therapies, has announced the appointment of Michael J. Mangano as president and CEO. Mangano will be responsible for leading global business activities, including the rapid development, regulatory approval and commercialization of ABK’s unique medical device technologies….

See original story here ABK Biomedical has raised more than $9 million in an over-subscribed round of equity funding that closed last August.  The larger equity base has allowed the company to borrow $3 million from the Atlantic Innovation Fund. The Halifax-based medical device maker revealed that it closed the Series A funding round – one…

See original article in LINK Magazine Every year brilliant discoveries are made in Dalhousie University’s research labs but without commercialization support many of those discoveries may never lead to potential social or economic benefits. The Industry Liaison and Innovation (ILI) Office, which is the business development arm of the university, is working to get those…

See original article in LINK Magazine Diagnostic Radiology Professor, Dr. Daniel Boyd had just moved from the Republic of Ireland when he walked into Dalhousie’s Industry Liaison and Innovation Office to discuss an innovative idea he had to develop an X-ray visible technology in the treatment of cancerous tumors. In an ironic twist of fate,…

See original Entrevestor article by Peter Moreira Two Halifax medtech companies, ABK Biomedical and Densitas, will travel to San Francisco next month to take part in the Dose of the Valley – a mentoring and networking event for Canadian life sciences companies. The Bay Area is renowned as the global hotbed for information technology startups, and for years Canadian IT companies…

2015 © Copyright - Bionova